Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Kanetsky

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2019
Big Returns on InvestmentPeter A Kanetsky
The British Journal of Dermatology|May 21, 2026
Enhanced Polygenic Risk Scores for Melanoma PredictionNancy E Thomas, Peter A Kanetsky
Journal of Pain and Symptom Management|December 9, 2008
Development of a novel location-based assessment of sensory symptoms in cancer patients: preliminary reliability and validity assessmentAdam R Burkey, Peter A Kanetsky
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2017
Marshaling the Translational Potential of <i>MC1R</i> for Precision Risk Assessment of MelanomaPeter A Kanetsky, Jennifer L Hay
Scientific Reports|December 25, 2019
Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancerRachel Howard, Peter A Kanetsky, Kathleen M Egan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Vitamin D and Melanoma: What Do We Tell Our Patients?Vernon K Sondak, Bryan McIver, Peter A Kanetsky
Annals of Epidemiology|September 5, 2019
Sociodemographic and lifestyle factors associated with the neutrophil-to-lymphocyte ratioRachel Howard, Aaron Scheiner, Peter A Kanetsky, et al.
The Clinical Journal of Pain|January 3, 2012
Natural variation in the μ-opioid gene OPRM1 predicts increased pain on third day after thoracotomyEdward Andrew Ochroch, Anil Vachani, Allan Gottschalk, et al.
The Journal of Investigative Dermatology|December 17, 2009
Melanoma molecular subtypes: unifying and paradoxical resultsNancy E Thomas, Peter A Kanetsky, Colin B Begg, et al.
Statistical Applications in Genetics and Molecular Biology|December 4, 2018
A practical approach to adjusting for population stratification in genome-wide association studies: principal components and propensity scores (PCAPS)Huaqing Zhao, Nandita Mitra, Peter A Kanetsky, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 3, 2019
Big Returns on InvestmentPeter A Kanetsky
The British Journal of Dermatology|May 21, 2026
Enhanced Polygenic Risk Scores for Melanoma PredictionNancy E Thomas, Peter A Kanetsky
Journal of Pain and Symptom Management|December 9, 2008
Development of a novel location-based assessment of sensory symptoms in cancer patients: preliminary reliability and validity assessmentAdam R Burkey, Peter A Kanetsky
Cancer Prevention Research (Philadelphia, Pa.)|December 17, 2017
Marshaling the Translational Potential of <i>MC1R</i> for Precision Risk Assessment of MelanomaPeter A Kanetsky, Jennifer L Hay
Scientific Reports|December 25, 2019
Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancerRachel Howard, Peter A Kanetsky, Kathleen M Egan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
Vitamin D and Melanoma: What Do We Tell Our Patients?Vernon K Sondak, Bryan McIver, Peter A Kanetsky
Annals of Epidemiology|September 5, 2019
Sociodemographic and lifestyle factors associated with the neutrophil-to-lymphocyte ratioRachel Howard, Aaron Scheiner, Peter A Kanetsky, et al.
The Clinical Journal of Pain|January 3, 2012
Natural variation in the μ-opioid gene OPRM1 predicts increased pain on third day after thoracotomyEdward Andrew Ochroch, Anil Vachani, Allan Gottschalk, et al.
The Journal of Investigative Dermatology|December 17, 2009
Melanoma molecular subtypes: unifying and paradoxical resultsNancy E Thomas, Peter A Kanetsky, Colin B Begg, et al.
Statistical Applications in Genetics and Molecular Biology|December 4, 2018
A practical approach to adjusting for population stratification in genome-wide association studies: principal components and propensity scores (PCAPS)Huaqing Zhao, Nandita Mitra, Peter A Kanetsky, et al.
Pageof 18